Clinical Trials Browser

OTHER × Diabetes Mellitus, Insulin-Dependent, 12 × 30 days × Clear all

NCT05426005 2026-05-22

Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer

Phase 1/2 Recruiting

Gastrointestinal

Turcot syndrome, Diabetes Mellitus, Insulin-Dependent, 12, Colorectal Neoplasms

NCT05571293 2026-05-22

NEST-1

Phase 2 Active not recruiting

26 enrolled 15 charts

Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Colorectal Neoplasms

NCT04253080 2026-05-20

ENZYMELA

Phase NA Completed

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

NCT06564623 2026-05-08

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Phase 1 Recruiting

Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Biliary Tract Neoplasms, Carcinoma